Real-world pharmacovigilance analysis and mechanistic exploration of JAK inhibitor-associated skin tumor adverse events using FAERS, VigiBase, and network pharmacology.
Feng Y, Li S, Li C
Journal of the American Academy of DermatologyIn the feed 4 Aug 2026, published online 4 Aug 2026, issue 2026 Aug 04, added to PubMed 4 Aug 2026
Topics: Skin cancer & tumorsJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42550112 · DOI 10.1016/j.jaad.2026.07.042